Yu Jonathan Yen-Wen sold $8K of IRON
Yu Jonathan Yen-Wen (Chief Operating Officer) sold 100 shares of Disc Medicine, Inc. (IRON) at $82.50 on 2026-07-07 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A COO open-market sale of 100 shares at $82.50 under a pre-arranged 10b5-1 plan is generally treated as routine compliance rather than a fundamental update.
Market read
Traders may note the filing for completeness, but it is unlikely to drive a material repricing without additional corroborating catalysts.
What to watch
The article provides only one small sale; it does not include any concurrent buys, option exercises, or broader insider activity trends that would strengthen inference.
Background
The article is a SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).
Ticker impact
Disc Medicine COO Yu Jonathan Yen-Wen sold 100 shares at $82.50 on 2026-07-07 under a pre-arranged 10b5-1 plan, per Form 4.
Likely minimal to no immediate price impact; any effect would be sentiment-only and short-lived.
The filing is a Form 4 insider transaction with modest size ($8,250) and explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
No clear sector read-through from a single small 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Even 10b5-1 sales can coincide with internal expectations of near-term risk, so traders may watch for follow-on insider activity or changes in trading patterns.
Key entities
- issuerDisc Medicine, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderYu Jonathan Yen-Wen
Chief Operating Officer who sold shares under a 10b5-1 plan.
